Nexus Surgical appoints Ashish Mishra as independent director
- Ashish Durgaprasad Mishra appointed as Independent Non-Executive Director
- Five-year term runs from September 2, 2026, to September 1, 2031
- Appointment requires approval at the 35th Annual General Meeting
- Mishra brings expertise in financial oversight and industry regulations

*this image is generated using AI for illustrative purposes only.
Nexus Surgical and Medicare Limited has appointed Ashish Durgaprasad Mishra as an Independent Non-Executive Director. The appointment takes effect from the close of business on September 2, 2026.
The Board of Directors approved the move during its meeting held on September 2, 2026, acting on the recommendation of the Nomination and Remuneration Committee. The appointment is subject to approval by members at the company’s ensuing 35th Annual General Meeting.
Appointment Details
Mishra will serve for a period of five consecutive years, from September 2, 2026, to September 1, 2031. He holds Director Identification Number (DIN) 10014935.
| Detail | Information |
|---|---|
| Name | Ashish Durgaprasad Mishra |
| DIN | 10014935 |
| Role | Independent Non-Executive Director |
| Term Start | September 2, 2026 |
| Term End | September 1, 2031 |
| Approval Status | Subject to AGM approval |
Profile and Compliance
The company disclosed that Mishra possesses understanding of financial statements, forecasting, and risk management. He also holds deep knowledge of the industry’s market trends and regulatory frameworks.
The filing confirms that Mishra is not related to any existing director of the company. He is not debarred from holding office by any SEBI order or other authority, nor is he disqualified under Section 164 of the Companies Act, 2013.
Historical Stock Returns for Nexus Surgical & Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.84% | +32.34% | +28.81% | +29.43% | +33.59% | 0.0% |
How might Ashish Mishra's expertise in risk management and regulatory frameworks influence Nexus Surgical's strategic approach to upcoming healthcare compliance changes?
What specific operational or financial initiatives is the Board likely to prioritize under the guidance of this new Independent Non-Executive Director over the next five years?
Could the addition of Mishra to the board signal a shift in Nexus Surgical's governance structure aimed at attracting institutional investors or improving ESG ratings?































